Federal Register / Vol. 71, No.
31 / Wednesday, February 15, 2006 / Notices 7983
Contact Person: Sathasiva B. Kandasamy,
PhD, Scientific Review Administrator,
Extramural Project Review Branch, Office of
Scientific Affairs, National Institute on
Alcohol, Abuse and Alcoholism, Bethesda,
MD 20892–9304, (301) 443–2926,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: February 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1388 Filed 2–14–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Initial Review Group.
Date: March 2–3, 2006.
Time: 8:15 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, Silver Spring, MD
20910.
Contact Person: Jeffrey M. Chernak, PhD,
Scientific Review Administrator, Office of
Review, National Institute of Nursing
cprice-sewell on PROD1PC66 with NOTICES
Research, 6701 Democracy Plaza, Suite 710,
MSC 4870, Bethesda, MD 20892, (301) 402–
6959, Chernak@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
VerDate Aug<31>2005 13:17 Feb 14, 2006 Jkt 208001
Dated: February 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1389 Filed 2–14–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Simulations for Drug Related Science
Education.
Date: March 1, 2006.
Time: 10:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: February 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1390 Filed 2–14–06; 8:45 am]
BILLING CODE 4140–01–M
PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\15FEN1.SGM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse,
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict Meeting.
Date: March 7, 2006.
Time: 4:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Murat Oz, PhD, Health
Scientist Administrator, Office of Extrumural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Neuroscience Center, Rm. 229,
MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892, 301–435–1433,
moz2@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict Meeting.
Date: March 7, 2006.
Time: 5:30 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Murat Oz, PhD., Health
Scientist Administrator, Office of Extrumural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Neuroscience Center, Rm. 229,
MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892, 301–435–1433,
moz2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: February 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1391 Filed 2–14–06; 8:45 am]
BILLING CODE 4140–01–M
15FEN1